Perrigo Company plc
NYSE:PRGODrug Manufacturers - Specialty & Generic
-$0.20 today
- Market cap
- $2.35B
- Beta
- 0.52
- P/E (TTM)
- -0.8
- EPS (TTM)
- -$13.10
- Dividend yield
- 11.65%
Volume 2.57M
Average 2.96M
PRGO Interest Expense
Cost of servicing the company's debt during the period.
Perrigo Company plcNYSE: PRGO
Interest Expense · Q2 FY2026 · quarter ended Jun 2026
Interest expense declines year over year
Q2 FY2026 interest expense of $38.4M fell 3.0% year over year, ahead of the -9.0% change in trailing-twelve-month interest expense. Sequentially, it fell 5.9% from the prior quarter. Over 3 fiscal years it compounded at +1.4% a year.
Context
- Interest expense amounted to 3.8% of revenue in FY2025, down 0.5 pp from a year earlier.
- Interest expense increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -3.0% holds above the trailing-twelve-month pace of -9.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Expense history
USD · from the income statement
- Latest · FY2025
- 162.5M USD
- Year-over-year change
- -13.5%
- 4-year CAGR
- +6.8%
| Period | Period end | Interest Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 162.5M | -13.5% |
| FY2024 | 2024-12-31 | 187.8M | +8.1% |
| FY2023 | 2023-12-31 | 173.8M | +11.4% |
| FY2022 | 2022-12-31 | 156M | +24.8% |
| FY2021 | 2021-12-31 | 125M | — |
Interest Expense vs competitors
How PRGO compares with its peers on the latest reported figures
- PRGO's LTM Jun 2026 interest expense of $163.1M is the 3rd highest of the 10 companies compared; the peer median is $13.99M.
- Its year-over-year change of -9.0% is the 4th highest of 8, against a peer median of -20.1%.
- Interest expense amounts to 3.9% of revenue for PRGO, versus a peer median of 2.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.61B | +8.7% | +3.1% | 14.8% | |
| LTM Sep 2026 | $400.8M | -22.6% | +5.1% | 11.9% | |
| LTM Jun 2026 | $163.1M | -9.0% | +1.4% | 3.9% | |
| LTM Sep 2026 | $43.28M | -20.1% | +0.7% | 2.9% | |
| LTM Mar 2026 | $42.09M | +53.7% | +56.6% | 5.3% | |
| LTM Sep 2026 | $13.99M | +450.7% | — | 2454.0% | |
| LTM Sep 2026 | $4.31M | -49.0% | +63.0% | 0.6% | |
| LTM Jun 2026 | $2.32M | — | — | 0.3% | |
HTFLHeartflow, Inc. Common Stock | LTM Sep 2026 | $16K | -99.9% | — | 0.0% |
| LTM Jun 2025 | $0 | — | +63.9% | 0.0% | |
| Peer median (excluding PRGO) | $13.99M | -20.1% | +30.8% | 2.9% | |
Competitors are the stored peer set for PRGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.14B | 4.45B | 4.66B | 4.37B | 4.25B |
| Cost of Revenue | 2.72B | 3B | 2.98B | 2.83B | 2.76B |
| Gross Profit | 1.42B | 1.46B | 1.68B | 1.54B | 1.49B |
| Gross Margin | 34.2% | 32.7% | 36.1% | 35.3% | 35.1% |
| Research & Development | 122M | 123.1M | 122.5M | 112.2M | 95.4M |
| Selling, General & Admin | 1.11B | 1.21B | 1.27B | 1.11B | 526.5M |
| Operating Expenses | 1.01B | 1.38B | 1.53B | 1.43B | 1.15B |
| Depreciation & Amortization | 312.2M | 338.6M | 359.5M | 325.9M | 337.5M |
| EBITDA | 695.9M | 355.5M | 525M | 433M | (797.9M) |
| EBITDA Margin | 16.8% | 8.0% | 11.3% | 9.9% | -18.8% |
| Operating Income | 410.4M | 78.9M | 151.9M | 112.9M | 343.3M |
| Operating Margin | 9.9% | 1.8% | 3.3% | 2.6% | 8.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 125M | 156M | 173.8M | 187.8M | 162.5M |
| Other Income / Expenses | (151.7M) | (218M) | (160.2M) | (193.6M) | (1.64B) |
| Income Before Tax | 258.7M | (139.1M) | (8.3M) | (80.7M) | (1.3B) |
| Pre-Tax Margin | 6.3% | -3.1% | -0.2% | -1.8% | -30.5% |
| Income Tax Expense | 389.6M | (8.2M) | (3.9M) | 80M | 104.4M |
| Net Income | (68.9M) | (140.6M) | (12.7M) | (171.8M) | (1.43B) |
| Net Margin | -1.7% | -3.2% | -0.3% | -3.9% | -33.5% |
| EPS (Basic) | (0.98) | (0.97) | (0.09) | (1.25) | (10.29) |
| EPS (Diluted) | (0.98) | (0.97) | (0.09) | (1.25) | (10.29) |
| Weighted Avg Shares | 133.6M | 134.5M | 135.3M | 137.4M | 138.5M |
| Weighted Avg Shares (Diluted) | 133.6M | 134.5M | 135.3M | 137.4M | 138.5M |
Perrigo Company plc
NYSE:PRGO
Intrinsic Alpha fair value
Locked
Current Price
$16.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.